Han‐Tsang Wu

636 citations
16 papers · 479 indexed · h-index 8
Topics
Ubiquitin and proteasome pathways (6 papers)Epigenetics and DNA Methylation (5 papers)RNA modifications and cancer (4 papers)
Partner nations
TaiwanMalaysiaCanada

In The Last Decade

Han‐Tsang Wu

14 papers receiving 472 citations

Peers

Han‐Tsang Wu
Comparison fields: 5 of 69
  • Molecular Biology 349
  • Cancer Research 132
  • Oncology 119
  • Genetics 47
  • Pulmonary and Respiratory Medicine 46
Replace Ji Eon Park with:
Ji Eon Park South Korea
Deok Yong Sim South Korea
Maoli Liang China
Wang Lunshan China
Ae Jin Jeong South Korea
Yeon A. Choi South Korea
Shih‐Ci Ciou Taiwan
Samiha Mateen United States
Ana Nedeljkovic-Kurepa United States
Honglin Situ China
Han‐Tsang Wu relative to Ji Eon Park South Korea Ji Eon Park's profile →
Citations per field
00.5×12×
Ji Eon Park · 1×
Citations per year

Countries citing papers authored by Han‐Tsang Wu

Since Specialization
Citations

This map shows the geographic impact of Han‐Tsang Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han‐Tsang Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han‐Tsang Wu more than expected).

Fields of papers citing papers by Han‐Tsang Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Han‐Tsang Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han‐Tsang Wu. The network helps show where Han‐Tsang Wu may publish in the future.

Co-authorship network of co-authors of Han‐Tsang Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Han‐Tsang Wu. A scholar is included among the top collaborators of Han‐Tsang Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Han‐Tsang Wu. Han‐Tsang Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 1
2 0
3 7
4 3
5 23
6 2
7 7
8 123
9 52
10 50
11 80
12 102
13 10
14 18
15 1
16
Three-Dimensional, Transgenic Cell Models to Quantify Space Genotoxic Effects
0

About Han‐Tsang Wu

Han‐Tsang Wu is a scholar working on Cancer Research, Molecular Biology and Oncology, having authored 16 papers that have together received 479 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (6 papers), Epigenetics and DNA Methylation (5 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Cancer Research (132 citations), Molecular Biology (349 citations) and Biochemistry (28 citations). Han‐Tsang Wu has collaborated with scholars based in Taiwan, Malaysia and Canada. Frequent co-authors include Kou‐Juey Wu, Shih-Han Kao, Kai‐Wen Hsu, Dar‐Ren Chen, Joseph Lin, Yeh Chen, Yu‐Ju Chen, Wei‐Chung Cheng, Chang‐Chi Hsieh and Hsiao‐Fan Chen. Their work appears in journals such as Nature Communications, Cancer Research and Fertility and Sterility.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026